期刊文献+

Research Progress on the Relationship between Coronary Artery Calcification and Chronic Renal Failure 被引量:22

Research Progress on the Relationship between Coronary Artery Calcification and Chronic Renal Failure
原文传递
导出
摘要 Objective: Coronary artery calcification (CAC) is thought to be a controlled metabolic process that is very similar to the formation of new bone. In patients with chronic renal failure (CRF), CAC is very common, and CAC severity correlates with the deterioration of renal lilnction. We summarized the current understanding and emerging findings of the relationship between CAC and CRF. Data Sources: All studies were identified by systematically searching PubMed, Embase, and CNKI databases for the terms "coronary calcification", "'chronic renal failure", '~vascular smooth muscle cell", and their synonyms until September 2017. Study Selection: We examined the titles and abstracts of all studies that met our search strategy thoroughly. The full text of relevant studies was evaluated. Reference lists of retrieved articles were also scrutinized for the additional relevant studies. Results: CRF can accelerate CAC progression. CRF increases the expression of pro-inflamrnatory factors, electrolyte imbalance (e.g., of calcium, phosphorus), parathyroid hon^none, and uremic toxins and their ability to promote calcification. These factors, through the relevant signaling pathways, trigger vascular smooth muscle cells to transtbrm into osteoblast-like cells while inhibiting the reduction of vascular calcification factors, thus inducing further CAC. Conclusions: Coronary heart disease in patients with CRF is due to multiple factors. Understanding the mechanism of CAC can help interventionists to protect the myocardium and reduce the prevalence of coronary heart disease and mortality. Objective: Coronary artery calcification (CAC) is thought to be a controlled metabolic process that is very similar to the formation of new bone. In patients with chronic renal failure (CRF), CAC is very common, and CAC severity correlates with the deterioration of renal lilnction. We summarized the current understanding and emerging findings of the relationship between CAC and CRF. Data Sources: All studies were identified by systematically searching PubMed, Embase, and CNKI databases for the terms "coronary calcification", "'chronic renal failure", '~vascular smooth muscle cell", and their synonyms until September 2017. Study Selection: We examined the titles and abstracts of all studies that met our search strategy thoroughly. The full text of relevant studies was evaluated. Reference lists of retrieved articles were also scrutinized for the additional relevant studies. Results: CRF can accelerate CAC progression. CRF increases the expression of pro-inflamrnatory factors, electrolyte imbalance (e.g., of calcium, phosphorus), parathyroid hon^none, and uremic toxins and their ability to promote calcification. These factors, through the relevant signaling pathways, trigger vascular smooth muscle cells to transtbrm into osteoblast-like cells while inhibiting the reduction of vascular calcification factors, thus inducing further CAC. Conclusions: Coronary heart disease in patients with CRF is due to multiple factors. Understanding the mechanism of CAC can help interventionists to protect the myocardium and reduce the prevalence of coronary heart disease and mortality.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2018年第5期608-614,共7页 中华医学杂志(英文版)
基金 This study was supported by a grant from the National Natural Science Foundation of China (No. 81573732).
关键词 Chronic Renal Failure Coronary Calcification Vascular Smooth Muscle Cell Chronic Renal Failure Coronary Calcification Vascular Smooth Muscle Cell
  • 相关文献

参考文献4

二级参考文献58

  • 1王开 ,钱家麒 ,Peter Stenvinkel ,Bengt Lindholm .终末期肾衰竭患者血清胎球蛋白A水平改变与临床预后的关系[J].中华肾脏病杂志,2005,21(2):72-75. 被引量:21
  • 2Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med, 2000, 342 : 1478-1483.
  • 3Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis:a cross-sectional study. Lancet,2003, 361 (9360) : 827-833.
  • 4US Renal Data System (USRDS):1999 Annual Data Report.Bethesda, National Institute of Diabetes and Kidney Diseases,1999.
  • 5Yokoyama K. Evaluation of coronary artery calcification in ESRD patients. Clin Calcium, 2004, 14:109-115.
  • 6Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium ×phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis, 1998, 31:607-617.
  • 7Levin NW, Hoenich NA. Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients. Curr Opin Nephrol Hypertens, 2001, 10:563 -568.
  • 8Giachelli CM, Jono S, Shioi A, et al. Vascular calcification and inorganic phosphate. Am J Kidney Dis, 2001, 38 (4 Suppl 1 ) : S34-S37.
  • 9Price PA, Lira JE. The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J Biol Chem, 2003, 278 : 22144-22152.
  • 10Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest, 2003,112 : 357-366.

共引文献46

同被引文献177

引证文献22

二级引证文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部